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Abstract 
    Energy balance and reproductive functions are closely linked in some species. 
The sex hormones (estrogens and androgens) are involved in the regulation of 
appetite, metabolism, body weight (BW), and body composition in mammals. 
Previously, we showed that the effects of testosterone on BW, appetite, and fat 
weight were markedly affected by alterations to the gonadal hormonal milieu. In this 
study, we examined whether testosterone administration changes food preferences 
and whether these effects of testosterone depend on gonadal status in female rats. 
We also evaluated the underlying mechanisms responsible for these effects, focusing 
on hypothalamic inflammation and endoplasmic reticulum (ER) stress. In 
gonadal-intact (sham) female rats, chronic testosterone administration promoted a 
preference for a high-fat diet (HFD) and increased BW gain, fat weight, and 
adipocyte size, whereas no such effects were observed in ovariectomized (OVX) 
rats. Testosterone administration increased hypothalamic interleukin-1 mRNA 
expression in the sham rats, but not the OVX rats. On the contrary, testosterone 
administration decreased the hypothalamic mRNA levels of ER stress-response 
genes in the OVX rats, but not the sham rats. These testosterone-induced alterations 
in OVX rats might represent a regulatory mechanism for preventing hypothalamic 
inflammation and the overconsumption of a HFD. In conclusion, testosterone’s 
effects on food preferences and the subsequent changes were affected by gonadal 
status. Testosterone-induced changes in hypothalamic inflammatory cytokine 
production and ER stress might be related to these findings. 
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1. Introduction
    It has been reported that energy balance and reproductive functions are closely 
linked in some species. The sex hormones (estrogens and androgens) contribute to 
the regulation of appetite, metabolism, body weight (BW), and body composition in 
mammals [1]. In females, estrogens play roles in preventing excessive BW gain and 
obesity. Food intake and BW are increased in ovariectomized (OVX) female 
animals, and these effects of ovariectomy can be counteracted via estradiol 
replacement [1-5]. On the contrary, the roles of androgens in BW regulation, 
appetite, and metabolism in females have not been fully clarified, although some 
studies have indicated that androgens might induce appetite dysregulation [1, 6-8] 
and visceral adiposity in females and experimental animals [1, 9-13]. Most of these 
previous studies focused on the effects of androgens in humans and experimental 
animals of reproductive age, whereas there are only limited data on the roles of 
androgens in the regulation of appetite and BW at other life stages, such as the 
menopause. In our previous studies, we showed that the effects of testosterone on 
BW, appetite, and fat weight were markedly affected by alterations in the gonadal 
hormonal milieu [14, 15]. The chronic administration of testosterone increased BW, 
appetite, and fat weight in gonadal-intact and OVX plus estradiol-supplemented rats, 
whereas testosterone caused reductions in these factors in OVX rats. These findings 
indicate that the effects of androgens on the regulation of BW, appetite, and 
metabolism might depend on the estrogenic milieu and reproductive age. 
    As noted above, the effects of androgens on BW and appetite are markedly 
affected by the estrogenic milieu [14, 15]. However, because the aforementioned 
studies were performed under fixed feeding conditions; i.e., standardized food was 
supplied to all experimental animals, the effects of androgens on food preferences 
could not be evaluated. As humans encounter various feeding environments, and 
most humans can freely select their favorite foods, the effects of androgens on 
dietary habits have significant implications. 
    In the present study, we examined whether the administration of testosterone 
affects food preferences and whether these effects depend on gonadal status in 
female rats. The hypothalamic levels of various factors involved in appetite and 
inflammation were measured to evaluate the mechanisms that underlie the effects of 
testosterone. We also examined the effects of testosterone on the expression of 
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hypothalamic endoplasmic reticulum (ER) stress-response genes and leptin because 
these factors promote a preference for a high-fat diet (HFD) [16-18]. 
2. Materials and Methods
2.1. Animals
    Adult female Sprague-Dawley rats were purchased and housed under 
controlled lighting (14 h light, 10 h dark cycle) and temperature (24℃) conditions. 
All animal experiments were conducted in accordance with the ethical standards 
of the animal care and use committee of the University of Tokushima. 
2.2. Chronic testosterone administration in sham-operated and ovariectomized 
female rats 
    Adult female rats were randomly divided into sham-operated (sham) and 
bilaterally ovariectomized (OVX) groups. All surgical procedures were carried out 
under sodium pentobarbital-induced anesthesia. In the sham groups, the ovaries 
were just touched with forceps. Four-six weeks after the operation, the rats of 
each group were further divided into control and testosterone-administered groups. 
Each rat in the testosterone-administered group was implanted with a silastic tube 
filled with crystalline testosterone (internal diameter: 3 mm; length of filled part: 
10 mm in the sham group and 15 mm in the OVX group), and each rat in the 
control group was implanted with an empty tube. After surgery, the rats were 
housed individually, and BW, calorie intake, and the extent of the rats’ preference 
for fat was measured weekly after the implantation procedure. Feed efficiency 
was calculated as follows: BW gain/energy intake. 
2.3. High-fat diet preference 
    The rats’ preference for a HFD was evaluated using standard-chow (SC) 
(type MF; Oriental Yeast Co. Ltd., Tokyo, Japan; 359 kcal/100 g, 12.8% of the 
provided calories were derived from fat) and a HFD (HFD-60; Oriental Yeast Co. 
Ltd., Tokyo, Japan; 506.2 kcal/100 g, 62.2% of the provided calories were derived 
from lard-based fat). The intake of the SC and HFD was measured and analyzed 
to assess the rats’ preference for fat. HFD preference was calculated as follows: 
(energy intake from HFD/total energy intake) × 100. 
2.4. Tissue sampling 
    At 3 weeks after the implantation procedure, the rats were killed by 
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decapitation under sevoflurane-induced anesthesia, and the weights of visceral fat, 
subcutaneous fat, and the uterus were measured. The brain, visceral and 
subcutaneous fat, and blood were collected. Serum was separated by 
centrifugation and stored at -20℃, and the brain and fat samples were stored at 
-80℃.
2.5. Hormone assay 
    Serum leptin levels were measured using a 125I-radioimmunoassay (RIA) kit 
(multi-species RIA kit, Linco Research Inc., MO, USA). The sensitivity of the 
assay was 1.0 ng/ml, and its inter- and intra-assay coefficients of variation were 
3.2% and 7.8%, respectively. 
2.6. Quantitative real-time polymerase chain reaction 
    Whole hypothalamic explants were dissected from the frozen brains, as 
described previously [14, 15]. Briefly, the brain sections were dissected out via an 
anterior coronal cut 2 mm anterior from the optic chasm, a posterior coronal cut at 
the posterior border of the mammillary bodies, parasagittal cuts along the 
hypothalamic fissures, and a dorsal cut 2.5 mm from the ventral surface. Total 
RNA was isolated from the hypothalamic explants and visceral fat using a 
TRIzol® reagent kit (Invitrogen Co., Carlsbad, CA, USA) and an RNeasy® mini 
kit (Qiagen Gmbh, Hilden, Germany). cDNA was synthesized with oligo 
(deoxythymidine) primers at 50℃ using the SuperScript III first-strand synthesis 
system for the real-time polymerase chain reaction (PCR; Invitrogen Co.). The 
PCR analysis was performed using the StepOnePlusTM real-time PCR system (PE 
Applied Biosystems, Foster City, CA, USA) and FAST SYBR® green. Standard 
curves generated from 4-fold dilution series of a sample were used for the relative 
quantification of the expression levels of each factor. The expression levels were 
normalized by dividing them by the level of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH). Dissociation curve analysis was also performed for 
each gene at the end of the PCR. Each amplicon generated a single peak. The 
primer sequences and annealing temperatures are shown in Table 1. The PCR 
conditions were as follows: the initial denaturation and enzyme activation were 
carried out at 95℃ for 20 s, followed by 45 cycles of denaturation at 95℃ for 3 s, 
and annealing and extension for 30 s. 
2.7. Histology 
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    Fixed visceral fat was dehydrated with ethanol and xylene and sliced into 
sections after being embedded in paraffin. Serial 4-μm-thick sections were stained 
with hematoxylin and eosin (H&E), and histological images were captured by a 
Zeiss Imager M2 microscope using the AxioVision version 4.8 acquisition 
software (Zeiss). The mean adipocyte area was determined using the software 
ImageJ. 
2.8. Statistical analyses 
    All results are presented as mean ± standard error of the mean (SEM) values. 
Two-way repeated analysis of variance (ANOVA) and the Student’s t-test were 
used for comparisons between the control and testosterone-administered groups. 
Student’s t-test was also used for the comparisons between the sham-control and 
OVX-control groups. P-values of <0.05 were considered significant. 
3. Results
    In the sham groups, BW (treatment: F(1,71)=22.7, P <0.01; time: F(3,71)=21.2, 
P <0.01; interaction: F(3,71)=1.96, P=0.13) and the post-implantation BW change 
(treatment: F(1,71)=49.6, P <0.01; time: F(3,71)=74.8, P <0.01; interaction: 
F(3,71)=6.74, P <0.01) differed significantly between the control and 
testosterone-administered rats (Figs. 1A and B). At 2 weeks (wk) and 3 wk after the 
implantation procedure, the mean BW of the testosterone-administered rats was 
significantly greater than that of the control group. Similarly, the 
testosterone-administered rats exhibited significantly greater mean BW changes at 1 
wk, 2 wk, and 3 wk after the implantation procedure than the control group. In the 
OVX groups, the mean post-implantation BW differed significantly between the 
control and testosterone-administered rats (treatment: F(1,79)=7.70, P <0.01; time: 
F(3,79)=21.9, P <0.01; interaction: F(3,79)=0.52, P=0.67) (Fig. 1C). However, the 
mean BW of the testosterone-administered rats did not differ from that of the control 
rats at any examined age. On the other hand, the mean post-implantation BW 
change (treatment: F(1,71)=0.002, P=0.97; time: F(3,79)=35.7, P <0.01; interaction: 
F(3,79)=0.77, P=0.51) did not differ significantly between the control and 
testosterone-administered rats (Fig. 1D), and the mean BW change exhibited by the 
testosterone-administered rats did not differ from that of the control rats at any 
examined age. 
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    In the sham groups, the mean post-implantation calorie intake of the control 
and testosterone-administered rats did not differ (treatment: F(1,71)=0.96, P=0.33; 
time: F(3,71)=480.94, P <0.01; interaction: F(3,79)=0.33, P=0.80), and the mean 
calorie intake of the testosterone-administered rats did not differ from that of the 
control rats at any examined age (Fig. 2A). On the other hand, the mean 
post-implantation HFD preference values of the control and 
testosterone-administered rats did not differ significantly (treatment: F(1,53)=11.2, 
P <0.01; time: F(2,53)=0.52, P=0.60; interaction: F(2,53)=0.33, P=0.72) (Fig. 2B). 
The mean HFD preference value of the testosterone-administered rats was 
significantly higher than that of the control rats at 2 wk and 3 wk after the 
implantation procedure. In the OVX groups, the mean post-implantation calorie 
intake (treatment: F(1,79)=0.002, P=0.97; time: F(3,79)=914.4, P <0.01; 
interaction: F(3,79)=0.50, P=0.68) and HFD preference (treatment: F(1,59)=2.32, 
P=0.14; time: F(2,59)=0.07, P=0.93; interaction: F(2,59)=0.68, P=0.51) values of 
the control and testosterone-administered rats did not differ significantly (Figs. 2C 
and D). The mean calorie intake and HFD preference values of the 
testosterone-administered and control rats did not differ at any examined age. 
    In the sham groups, the testosterone-administered rats exhibited significantly 
higher feed efficiency than the control rats (Fig. 3A), whereas in the OVX groups 
feed efficiency did not differ between the testosterone-administered and control rats 
(Fig. 3B). 
    In the sham groups, the total fat weight and adipocyte size of the 
testosterone-administered rats were significantly higher than those of the control rats 
(Figs. 4A and C), whereas in the OVX groups adipocyte size did not differ between 
the testosterone-administered and control rats (Figs. 4D and F). Total fat weight and 
adipocyte size of the OVX-control rats were significantly heavier and larger than 
those in sham-control rats (Fig. 4A, D, C and F) 
    In the sham groups, the testosterone-administered rats displayed a significantly 
higher mean hypothalamic interleukin (IL)-1 mRNA level than the control rats (Fig. 
5), whereas no differences in the serum leptin level or the hypothalamic mRNA 
levels of the other examined factors were seen between these two groups. In the 
OVX groups, the hypothalamic X-box binding protein 1 (Xbp)1S, Xbp1U, and 
CCAAT-enhancer-binding protein homologous protein (CHOP) mRNA levels of the 
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testosterone-administered rats were significantly lower than those of the control rats 
(Figs. 5). Serum leptin and hypothalamic IL-1 mRNA levels of OVX-control rats 
were significantly higher than those of Sham-control group, whereas hypothalamic 
Xbp1u mRNA level of OVX-control rats was significantly lower than that 
of Sham-control group (Figs. 5). 
4. Discussion
    In this study, we have shown that chronic testosterone administration resulted 
in a greater preference for a HFD and increases in BW gain, fat weight, and 
adipocyte size in gonadal-intact female rats (sham), whereas these effects of 
testosterone were not observed in OVX rats. In addition, feed efficiency; i.e., the 
ability to convert feed into weight, was increased by testosterone administration in 
the sham rats, whereas it was not altered in the OVX rats. As HFD consumption 
increases feed efficiency and body fat weight in rodents [19, 20], the increases in 
BW, body fat, and feed efficiency seen in the sham rats in the present study might 
have been caused by the testosterone-induced promotion of a preference for a HFD. 
As far as we know, this is the first study to examine the relationship between sex 
hormone status and food preference in females. As androgen-administered animals 
tend to exhibit ovulatory disorders, as well as changes in BW and fat mass, these 
animal models have been used to study the pathology and origins of polycystic 
ovary syndrome, which is a common cause of anovulation and metabolic 
abnormalities in women of reproductive age [21-23]. Although most of these studies 
were performed under standardized food conditions, a previous study showed that 
the consumption of a HFD exacerbates the effects of androgens on endocrine and 
metabolic phenotypes in female rats [23]. Therefore, when we examine the effects 
of androgens on BW and metabolic regulatory systems, we should take the effects of 
androgens on food preference into consideration. 
    In this study, we have shown that chronic testosterone administration increased 
hypothalamic IL-1 mRNA expression in sham rats. As it has been demonstrated that 
the consumption of a HFD increases hypothalamic inflammation and that this has 
unfavorable effects on the regulation of BW, metabolism, and food preferences [19, 
20], increased hypothalamic IL-1 expression might be related to greater body fat 
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weight and promote a preference for a HFD in testosterone-administered sham rats. 
Although HFD-induced obesity generally increases other hypothalamic 
inflammatory cytokines, such as TNF-α and IL-6, chronic testosterone 
administration did not affect hypothalamic TNF-α mRNA expression in sham rats 
in this study. We could not determine the mechanism underlying such discrepant 
effects of testosterone on hypothalamic inflammatory cytokines, and thus further 
examinations would be needed to clarify this point. On the other hand, chronic 
testosterone administration did not alter the hypothalamic expression of 
inflammatory genes, whereas it decreased the hypothalamic expression of ER 
stress-response genes, e.g., Xbp1S, Xbp1U, and CHOP, in OVX rats in the current 
study. As noted above, recent studies have found that marked ER stress is closely 
related to the pathophysiology of obesity and metabolic diseases [16, 24, 25]. 
Hypothalamic Xbp1S and CHOP are involved in the leptin sensitivity [25], 
and reduction of Xbp1S and CHOP improves glucose intolerance in mice fed the 
HFD [16]. XBP1U mRNA is an unspliced precursor form and its intron is 
removed to synthesis of XBP1S under stress condition [26]. It was reported that 
hypothalamic ER stress and inflammation are linked to the dysregulation of 
appetite and energy metabolism in experimentally obese animals [25]. In 
addition, it was demonstrated that a reduction in ER stress downregulated 
hypothalamic inflammation under chronic HFD-supplied conditions [25]. We 
speculate that the reduction in the hypothalamic expression of ER stress-
response genes observed in the testosterone-administered OVX rats in the 
present study might have represented a compensatory regulatory mechanism that 
prevents testosterone from causing the overconsumption of a HFD and the 
subsequent hypothalamic inflammation. We hypothesized that such regulatory 
mechanisms might be suppressed during the reproductive period in order to 
increase energy storage for fertility. It has also been reported that serum leptin 
plays a role in the regulation of food preferences, and that a lack of leptin activity 
promoted a preference for a HFD in rodents [17, 18]. Thus, we measured serum 
leptin levels in the current study; however, no significant differences in leptin 
levels were detected between the testosterone-administered and control rats. 
    In present study, total fat weight and adipocyte size of OVX rats were higher 
then those of sham rats. Similarly, hypothalamic IL-1 mRNA level of OVX rats was 
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higher than that of sham rats. Therefore, one possible explanation for the lack of the 
effects of testosterone administration in OVX rats might be that they had 
already gained too much weight (“saturated”) for testosterone to have any 
additional effects. Further examination would be needed to clarify these points. 
5. Conclusion
In summary, we have shown that chronic testosterone administration promoted a
preference for a HFD and increased BW gain, fat weight, and adipocyte size in
gonadal-intact female rats, whereas these effects of testosterone were not observed
in OVX rats. Thus, testosterone’s effects on food preferences and the subsequent
changes were affected by gonadal status. Testosterone-induced changes in
hypothalamic inflammatory cytokine expression and ER stress might be related to
these findings.
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Weekly changes in body weight (A, C) and body weight changes (% of the value seen 
before the administration of testosterone) (B, D) in the sham (upper) and ovariectomy 
(OVX) (lower) groups. Data are presented as mean ± standard error the mean (SEM) 
values. * P <0.05, ** P <0.01 vs. the control group at the same time point. 
Fig. 2. 
Cumulative calorie intake (A, C) and weekly changes in the degree of preference for the 
high-fat diet (HFD) (B, D) in the sham (upper) and OVX (lower) groups. Data are 
presented as mean ± SEM values. * P <0.05 vs. the control group at the same time 
point. 
Fig. 3. 
Feed efficiency (BW gain/energy intake) in the sham (left) and OVX (right) groups 
Data are presented as mean ± SEM values. ** P <0.01 vs. the control group. 
Fig. 4. 
Total fat (visceral and subcutaneous fat) weight (A, D), representative images (B, E), 
and mean adipocyte size of visceral fat (C, F) in the sham (upper) and OVX (lower) 
groups. Data are presented as mean ± SEM values. ** P <0.01 each other. # P<0.05, ## 
P <0.01 vs. the Sham-control group. 
Fig. 5. 
Serum leptin level and hypothalamic mRNA levels of OBRb (which encodes the leptin 
receptor), NPY, IL-1, tumor necrosis factor-α, Xbp1S, Xbp1U, and CHOP in the sham 
(upper) and OVX (lower) groups. Values of Sham-control group are expressed as 1.0. 
Data are presented as mean ± SEM values. * P <0.05, ** P <0.01 each other. ## P <0.01 
vs. the Sham-control group. OBRb: the gene encoding the leptin receptor, NPY: 
neuropeptide Y, IL-1: interleukin 1, TNF-α: tumor necrosis factor-α, Xbp1S: X-box 
binding protein 1S, Xbp1U: X-box binding protein 1U, and CHOP: 
CCAAT-enhancer-binding protein homologous protein. 






